Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

QP - the reprise > Law and Admin > Flashcards

Law and Admin Flashcards

1
Q

What’s new in legislation world

A
  • Canada added to White List in EMA
  • Part IV – ATMPs
  • Annex 21 – Importation of medicinal products
  • Windsor arrangement
  • Annex 16 has been incorporated into PIC/S (along with Annex 13)
  • EU vet regulation 2019/6
  • New Annex 1
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the Yellowcard and Black Triangle schemes?

A

Yellowcard = MHRA system for reporting issues with medicinal products, e.g. side effects, adverse events, counterfeit or fakes

EMA Black triangle = under intensive surveillance where we only have limited data of in market use. Used for new APIs, new combinations, new route of administration / drug delivery systems.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the 7 EMA scientific committees

A

CHMP – committee for medicinal products for human use
CVMP – committee for medicinal products for veterinary use
PRAC – pharmacovigilance risk assessment committee
COMP – committee for orphan medicinal products
HMPC – committee for herbal medicinal products
CAT – committee for advanced therapies
PDCO – paediatric committee

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

EMA – what is it and what does it do?

A

Responsible for scientific evaluation, supervision and safety monitoring of medicines in 27 MS and the EEA countries

Facilitates development and access to medicines, evaluate applications for marketing authorisations, monitor the safety of medicine across their lifecycle and provide reliable info on human and vet medicines in lay language

Provides a legal framework for pharmaceuticals to ensure medicines are safe. Based on Directive 2001/82/EC, 2001/83/EC and regulation 726/2004 (centralised authorisation procedure)
Grants licences under the centralised procedure, does not audit sites but delegates this duty to the MS competent authorities, the EMA passes an opinion which the European Commission considers when granting an authorisation.
7 scientific committees and a number of working parties which conduct the scientific work of the agency

Committee will provide scientific advice to companies researching and developing new meds, prepare scientific guidelines and regulatory guidance to help companies prepare marketing authorisation applications, contribute to the harmonisation of regulatory requirements in the EU and internationally. They will appoint a rapporteur and a co-rapporteur.
Operates databases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the EMA operated databases?

A

Eudralex – legislation and guidance

EudraGMP – licences and GMP certs

Eudra CT – CTAs

Eudravigilance – PV reporting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is NIMAR

A

Northern Ireland MHRA Authorised Route.

A list of prescription only medicines that can be supplied to NI if considered safe in GB to ensure supply of medicines. Mitigates risk of supply in NI from GB where the size of market means manufactures can’t be bothered with it.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Where do you find the rules for variations?

A

2012/1916 schedule 10A

EU 1234/2008

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the variation types?

A

Type 1 a – minor variations 12 months

Type 1 a IN- immediate notification within 14 days
Do and Tell
Answer provided within 30 days of submission

Type 1b- minor variation. 30 days from confirmation, hear nothing go ahead
Tell, Wait, Do

Type 2- major variations Wait for approval
Normally 60 days for first review but can then be extended almost as they wish

FLU - there’s a fast track process

Urgent Safety restrictions
If you’ve raise the issue then tell and get answer in 24 hrs
If authorities raise it then must submit variation within 15 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Examples of Ia variation

A

Change in name or API, starting material etc where site stays the same. Also dp manufacturer if not certifying there.

<10 fold in API batch size or reduction

Tightening of limits, addition of new in process test & limits

Minor changes to quantitive composition wrt excipients

Minor change to manufacturing process for OSD and oral solutions

Change in coat weight or capsule shell (cosmetic only)

Change to composition of primary pack for solid form

Change to primary pack supplier

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Examples of IaIN variation

A

Change to name of active substance

Change to name / address of manufacturer and test site inc release site if satisfactory inspection and appropriately authorised

Tightening of specification of dp subject to official batch release

Change to shape, debossing or other markings

Change to secondary or packing site

Change to pack size within preapproved range.

Change to packaging that includes product information.

Reduction in shelf life

New CEP from approved manufacturer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Examples of Ib variation

A

> 10 fold increase in batch size of API

Increasing / decreasing scale of biological / immunological with no change to process (e.g. duplication of line)

Addition or replacement of an in-process test as a
result of a safety or quality issue

Change to liquid API primary pack material

Extension or introduction of an API re-test
period/storage period supported by real time
data

Change in storage conditions of the active
Substance

Change to breakline

Change to manufacturing site where not meeting conditions of 1aIN

Minor change to manufacturing process for oral suspensions

> 10 fold increase in batch size

Change to type of container for Solid, semi-solid and non-sterile liquid pharmaceutical forms

Change to pack size outside the range currently
approved

Extension of shelf life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Examples of Type II variation

A

Pretty much anything steriles or biological / immunological

New API manufacturer, new route of synthesis, substantial change to process

New herbal geographical source , manufacturing route or production

Changing quality critical in process tests

Changing flu strain

Changing the design space

Changes to formulation (excipients or api) that have a quality critical function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the new EU veterinary regulation?

A

2019/6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the new vet variation regulation?
What are the two variation types?

A

2021/17

Variations Not Requiring Assessment VNRA
Variations Requiring Assessment VRA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is Role and legal status of the BP?

A

BP is an annually published collection of quality standards for medicinal products in the UK.

BP is governed under 2012/1916, legal basis is 1968 medicines act. 2012/1916 talks about routine updates to the content.

Actual BP itself contains monographs for drug substances, excipients and formulated preparations.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is PIC/S and how is it applied?

A

(Chris Expects Trouble Half the Time) -Cooperation, exchange, training, harmonization of GMP and Tech standards

  • Strengthen Cooperation to maintain confidence
  • Provide framework for Exchange of info
  • Coordinate mutual Training for inspectors
  • Harmonization of GMP
  • Harmonization of Technical standards

54 authorities, harmonised GMP and quality systems for MP, treaty between countries to recognise inspections
Pharmaceutical Inspection Co-operation Scheme

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the requirements for a PQR (drug product)

A

Scrap Divers Wear PVC
S - Starting materials and packing review - source and supply chain
C - Critical IPC and finished product test results review
R - Rejected batches
P - Previous CAPA review
P - Planned Changes
D - Deviations
V - Variations
R - Recalls, returns, complaints
S - Stability review
P - Post marketing commitments
V - Validation / qualification of utilities
C - Chapter 7 outsourcing review

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Who would you involve in a product recall? Detail the process

A
  • Logistics - to find out where it is, how quickly it flies off the shelf
  • Legal
  • Medical - patient impact assessment of defect
  • PV - trends of complaints, product history
  • Production - if involved in defect generation
  • QC - for testing input (if required)
  • QA
  • Comms team if thinking class 1 recall
19
Q

What are the recall classes and how long before you initiate recall?

A

Class 1 – Critical defect
Class 2 – Major defect
Class 3 – Minor defect
Class 4 - Caution in Use

or no recall

Mandated recall initiate times:
Intercity 125 : within 1 day, within 2 days (48 hrs), within 5 days

20
Q

What is ICH and how is it applied?

A

International Council for Harmonization
5 steps to implementing the guidelines. 1 = consensus its required, 2 = technical document generated and adopted, 3 = regulatory consultation, 4 = adoption (who’s gonna when it’s finished), 5 = implemented. ICH was founded by EC, US and Japan, but now has more members.

ICH is not technically law – it’s for harmonization. Once it’s at step 5, update national / regional procedures as required.

21
Q

What are the EU GMP regs / directives?

A

2017/1569 – GMP for IMPS (regulation)
2017/1572 – GMP for medicinal products (directive)

22
Q

What’s the structure of an MIA?

A
  • MIA Number
  • Name of MA holder
  • Address of site manufacturing and importing and Legally registered address
  • Scope of license and dosage forms
  • Name of MHRA rep granting license
  • Date
  • Variation history
  • Sites covered (separate annexes for each)
  • Product types allowed for Manufacture and Import
  • Names of Production Manager, QPs, RPs, Heads of Quality, Heads of Manufacture and Quality Control
  • date of inspection on which authorisation granted and scope of last inspection
  • Products authorised to be manufactured/imported
  • Name and address of testing laboratories
  • Name and address of warehouses

For MIA IMPs there is no product list, just the types of products you can import that are IMP.

23
Q

What is the current UK legislation?

A

1968 Medicines Act. Came about as an output from the Thalidomide scandal

2012/1916 Human Medicines Regulations
2004/1031 Clinical Trial Regulations as amended by 2019/744
2013/2033 Veterinary Medicines Regulations

Medicines and Medical Devices Act 2021

The Misuse of Drugs Act 1971
2001/3998 - Misuse of Drugs Regulations 2001

24
Q

What does 2001/3998 misuse of drugs regs 2001 include?

A

Schedules 1 - 5 list the drugs in classification of reducing seriousness and who can prescribe them plus how they must be stored

25
Q

WDA structure?

A
  • Name and address of applicant
  • WDA authorisation text
  • WDA number and holder
  • MHRA approver
  • Variation history
  • Scope of the WDA - what each place can hold
  • Names of the RPs
26
Q

What’s the DMRC and Veterinary equivalent?

A
  • Defective Medicines Report Centre. Role is to minimize the hazards posed by distribution of defective medicines.
  • For veterinary, is a report form online that goes to the VMD.
27
Q

Where are the legal duties for a QP in 2013/2033?

A

Schedule 2 para 11

They are the same as human MP duties.

28
Q

What are the duties relating to the Vet QPPV (schedule 1)

A

Establishes and maintains a system that collects and collates details of all suspected adverse reactions reported to the marketing authorisation holder;

Answers any request from the Secretary of State for information on the benefits and risks afforded by a veterinary medicinal product fully including the volume of sales of the veterinary medicinal product concerned and, if available, details of prescriptions;

29
Q

What is the EDQM and what do they do?

A

European Directorate for the Quality of Medicines & Healthcare
The EDQM is a directorate of the Council of Europe. It has responsibility for:-
* Maintaining the European Pharmacopoeia
* Supplying chemical reference substances (CRS) and biological reference preparations (BRP) as well as reference spectra for the tests and assays to be carried out in accordance with the official methods prescribed in the European Pharmacopoeia.
* Implement the CEP process for ‘Certification of Suitability to the monographs of the European Pharmacopoeia’.

30
Q

Talk to me about CEPs?

A

CEPs are recognised by the signatory parties of the Convention on the Elaboration of a European Pharmacopoeia, i.e. all Council of Europe member states and the European Union. They are also recognised by other countries, e.g. Canada, Australia, New Zealand, Tunisia and Morocco

The CEP certifies that by applying the relevant monographs of the Ph. Eur., if necessary with an annex attached to the certificate of additional tests and their limits, it is possible to check whether or not the quality of the substance is suitable for use in medicinal products.

In other words, it ensures that all possible impurities from this particular route (including source materials) can be fully controlled by the requirements of the monographs and any additional tests added to the certificate. The CEP certifies that the active substance complies with Ph Eur and the monograph is enough to control quality.

A CEP says nothing about the GMP used to manufacture the AS.

31
Q

How do you report an animals reaction to medicine or microchip?

A

There’s a form on the GOV website

32
Q

What’s different about importing a veterinary product?

A

They can be imported by any number of different people:

1) The holder of the MA
2) WDA holder
3) A vet or pharmacist can import anything
4) A QP that is permitted to supply that product.

33
Q

What’s POM-V and who can prescribe?

A

Prescription Only Medicine – Veterinarian.

A veterinary medicinal product which may only be supplied to the client once it has been prescribed by a veterinary surgeon following a clinical assessment of an animal, or a group of animals, under the veterinary surgeon’s care

34
Q

What’s POM-VPS and who can prescribe?

A

Prescription-Only Medicine – Veterinarian, Pharmacist, Suitably Qualified Person (SQP)

A medicine for food-producing animals (including horses).
Prescribed by any Registered Qualified Person (RQP means a veterinarian, pharmacist or an appropriately qualified SQP).

A clinical assessment of the animal(s) is not required when prescribing this category of veterinary medicine and the animal does not have to be seen by the prescriber. However sufficient information about the animal and the way it is kept must be known to the prescriber in order to prescribe and supply appropriately.
Non-Food Animal Medicine – Veterinarian, Pharmacist, Suitably Qualified Person

A medicine for companion animals may be supplied by any RQP (a veterinarian, pharmacist or Suitably Qualified Person) provided the requirements for supply are met. These medicines do not require a prescription

35
Q

When do contract labs not need a GMP licence from MHRA

A

When they do EM for non-steriles

36
Q

When do contract labs need to have a GMP certificate and be inspected by MHRA?

A

MHRA inspects labs used for:
* testing medicinal products (inc IMPS) if used for batch release
* testing radiopharms
* stability testing
* EM and process sim for steriles
* Biological testing as per Annex 2
All labs doing this stuff need to be listed on the MIA and MAH licences.

37
Q

What do brokers do?

A

Brokers act as intermediaries in transactions and do not physically handle the products. A broker does not buy or sell the products, They also don’t buy / sell products, own the products or physically handle the products.

38
Q

What do brokers need?

A

Brokers need to be registered with MHRA

Brokers need a QMS and follow GDP.

They need to keep a record of all brokerings.

Brokers need to be able to participate in recalls and inform of suspected falsified medicines

Brokers need to verify their customers have appropriate authorisations

39
Q

What types of site licenses are available?

A

MIA
WDA
MIA IMP
Specials Licence
Veterinary Licence

API registration
Broker registration

40
Q

What are the acts of Parliament relevant to pharmaceutical industry

A

Human Medicines Act 1968
Misuse of Drugs Act 1971
Medicines and Medical Devices Act 2021

41
Q

What is the international recognition procedure

A

Process MHRA uses to streamline drug approval (but can still reject). Recognises the approval in certain countries

42
Q

What are the IRP countries?

A

Japan
EU
Switzerland
US
Singapore

Australia
Canada

JESUS AC

43
Q

How long does a CEP last?

A

Fist issue must be revalidated within 5 years. After that eternity

44
Q

What are conditional marketing authorisations (CMAs)

A

The MHRA has introduced a national Conditional Marketing Authorisation (CMA) scheme for new medicinal products in Great Britain effective from 1 January 2021.

The scheme is intended for medicinal products that fulfill an unmet medical need. Examples would be for serious and life-threatening diseases where no satisfactory treatment methods are available or where the product offers a major therapeutic advantage.
The MHRA may grant a CMA where comprehensive clinical data is not yet complete, but it is judged that such data will become available soon.

QP - the reprise (14 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions